Earnings Call · Q2 FY2021·2021-07-29

Q2 21EPS +7.69%·Rev n/aQ1 21EPS -12.96%·Rev n/aQ4 20EPS -14.89%·Rev n/aQ3 20EPS -100.00%*·Rev n/a⚠ consensus missing

PTC THERAPEUTICS, INC. PTCT

Kylie O'Keefe — Investor Relations

Stuart Peltz — Chief Executive Officer

Matthew Klein — Chief Development Officer

Eric Pauwels — Chief Business Officer

Emily Hill — Chief Financial Officer

+0.2%1d on move date+0.7% vs SPY3d+0.8%5d+4.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PTCT calls or request research access.

More PTCT calls Browse calls Request research access